Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations

Investor RelationsSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Stock price graph
     

Spectrum Pharmaceuticals is a commercial-stage biotechnology company with a focus in oncology. The Company's strategy is comprised of acquiring and developing a broad and diverse pipeline of late-stage clinical and commercial products; establishing a commercial organization for its approved drugs; continuing to build a team with people who have demonstrated skills, passion, commitment and have a track record of success in its areas of focus; and, leveraging the expertise of partners around the world to assist it in the execution of its strategy.

Spectrum Pharmaceuticals' stock is traded through the Nasdaq Global Market System

Ticker Symbol: SPPI

View all »   RSSRecent Releases

Oct 30, 2014
Spectrum Pharmaceuticals Announces Third Quarter 2014 Financial Results Teleconference and Webcast

Sep 18, 2014
Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs

View all »Events & Presentations

Nov 6, 2014 at 1:30 PM PT
Third Quarter 2014 Financial Results Conference Call

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPISpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Price:
7.65
Change:
+ 0.15
Day High:
7.75
Day Low:
7.44
Volume:
936,200
4:00 PM ET on Oct 30, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder ToolsSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Print Email

Search IRSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company